AstraZeneca expands B'luru hub with Rs 166 cr
New Delhi: Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 crore, creating 400 jobs to boost Research and Development, global services and AI innovation.
The new facility will house nearly 1,300 employees, including 400 new jobs, supporting the company's capabilities in AI-powered innovation across Research and Development, global business services, IT, and digital health operations, AstraZeneca said in a statement.
'Our global hub in Bengaluru is a strategic investment that will play a vital role in advancing AstraZeneca's bold ambition to deliver 20 new medicines by 2030 -- by strengthening automated, scalable, data-driven, and patient-centric solutions,' AstraZeneca Vice President, Global Business Services, Jackie Crockford said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
12 hours ago
- Hans India
AstraZeneca expands B'luru hub with Rs 166 cr
New Delhi: Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 crore, creating 400 jobs to boost Research and Development, global services and AI innovation. The new facility will house nearly 1,300 employees, including 400 new jobs, supporting the company's capabilities in AI-powered innovation across Research and Development, global business services, IT, and digital health operations, AstraZeneca said in a statement. 'Our global hub in Bengaluru is a strategic investment that will play a vital role in advancing AstraZeneca's bold ambition to deliver 20 new medicines by 2030 -- by strengthening automated, scalable, data-driven, and patient-centric solutions,' AstraZeneca Vice President, Global Business Services, Jackie Crockford said.
Time of India
19 hours ago
- Time of India
AstraZeneca invests Rs 166 crore to expand Bengaluru operations
Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating 400 new jobs. The upgraded facility will support around 1,300 employees and enhance the company's capabilities in AI-driven R&D, global business services, IT, and digital health, strengthening its presence in India. This investment follows AstraZeneca's recent expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The company's workforce in India will increase to 4,000 employees, highlighting India's growing significance in AstraZeneca's global operations. The enhanced Bangalore facility will house nearly 1,300 staff members and function as a comprehensive centre supporting AstraZeneca's primary operations in clinical research, AI-driven healthcare solutions, global business services, and regulatory compliance. "Our global hub in Bengaluru is a strategic investment that strengthens our ambition to deliver 20 new medicines by 2030," said Jackie Crockford, VP of global business services at AstraZeneca. You Can Also Check: Bengaluru AQI | Weather in Bengaluru | Bank Holidays in Bengaluru | Public Holidays in Bengaluru The new facility will serve as a dynamic hub advancing AstraZeneca's critical priorities, including advanced clinical research across global therapeutic areas, development of AI-powered healthcare and digital health technologies, centralized data analytics to improve clinical trial efficiency and patient outcomes, and specialized support for global regulatory compliance and pharmacovigilance. Karnataka health minister Dinesh Gundu Rao said, "This aligns with our vision to drive high-value employment and make Bangalore a biotechnology and R&D powerhouse. "
New Indian Express
a day ago
- New Indian Express
AstraZeneca expands Bengaluru hub with Rs 166 crore investment; to create 400 jobs
BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs 166 crore investment. The new facility will house about 1,300 employees and generate 400 new jobs. This is AstraZeneca's second major investment in India within a year, following the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The combined workforce now at AstraZeneca India Private Limited (AZIPL) will reach close to 4,000 employees. The company said the new facility will serve as a dynamic hub dedicated to advancing AstraZeneca's critical priorities including advanced clinical research supporting AstraZeneca's global therapeutic areas; development of AI-powered; healthcare solutions and digital health technologies. Apart from these, the new facility will help centralise data analytics to enhance clinical trial efficiency and patient outcomes. "Our Global Hub in Bengaluru is a strategic investment that will play a vital role in advancing AstraZeneca's bold ambition to deliver 20 new medicines by 2030 — by strengthening automated, scalable, data-driven, and patient-centric solutions. This step reflects our commitment to tapping into the world-class talent and ecosystem available in Karnataka to power the next generation of scientific innovation," said Jackie Crockford, Vice President, Global Business Services, AstraZeneca. "This hub enhances our R&D capabilities by connecting us with India's exceptional scientific and technological expertise. The expansion will accelerate the development of innovative medicines and help us deliver across R&D, ultimately benefiting patients around the world," said Magnus Nord, Vice President, Global Patient Safety BioPharma, AstraZeneca. The global hub in Bengaluru is dedicated to Research & Development (R&D), Global Business Services (GBS), IT & Digital Health capabilities, playing a key role in advancing scientific discovery and innovation within the enterprise. The company also said that the GITC in Chennai serves as a strategic hub for IT, GBS, Global supply chain & strategy, supporting core business operations with high-impact, technology-driven solutions.
